Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Hematology/Oncology Clinics of North America|July 27, 2018
Upfront Matched Unrelated Donor Transplantation in Aplastic AnemiaKatherine Clesham, Robin Dowse, Sujith SamarasingheLeukemia|April 3, 2022
Identification of a c-MYB-directed therapeutic for acute myeloid leukemiaKatherine Clesham, Vanessa Walf-Vorderwülbecke, Luca Gasparoli, et al.British Journal of Haematology|November 17, 2024
Real-world experience of paediatric acute promyelocytic leukaemia in the United Kingdom and IrelandAditi Vedi, Sarah Maria Leiter, Irum Latif Memon, et al.Transplantation|October 26, 2020
Real-world Outcomes With Rituximab-based Therapy for Posttransplant Lymphoproliferative Disease Arising After Solid Organ TransplantDavid M Burns, Katherine Clesham, Yan A Hodgson, et al.Blood Advances|May 2, 2025
Impact of shared HLA determinants between patient and losing cord blood unit on relapse after double cord blood transplantationRobert Wynn, Fernanda Volt, Philippe Guardiola, et al.Bone Marrow Transplantation|April 22, 2026
Outcomes of 544 Patients with t(6;9)/DEK::NUP214 acute myeloid leukemia undergoing allogeneic stem cell transplantation: an EBMT study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP)Fabio Andreozzi, Jacques-Emmanuel Galimard, Johan Maertens, et al.Bone Marrow Transplantation|March 24, 2025
Current use of donor lymphocyte infusions after allogenic stem cell transplantation in Europe: a survey on behalf of the cellular therapy and immunobiology working party of the EBMTNicole Santoro, Christoph Schmid, Moniek de Witte, et al.American Journal of Hematology|October 18, 2018
Impact of T-cell depletion strategies on outcomes following hematopoietic stem cell transplantation for idiopathic aplastic anemia: A study on behalf of the European blood and marrow transplant severe aplastic anemia working partySujith Samarasinghe, Katherine Clesham, Simona Iacobelli, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2023
Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALLAngus Hodder, Avijeet K Mishra, Amir Enshaei, et al.Blood Cancer Journal|April 15, 2024
Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access schemeMacarena Oporto Espuelas, Saskia Burridge, Amy A Kirkwood, et al.Pageof 1